Capital Advisors Ltd’s Amedisys AMED Stock Holding History

Capital Advisors Ltd’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-56	Closed	-$6K	–	1332
2025 Q2	$6K	Hold	56	–	–	﹤0.01%	877
2025 Q1	$5K	Sell	56 -3	-5%	-$277	﹤0.01%	904
2024 Q4	$5K	Buy	59 +11	+23%	+$1.01K	﹤0.01%	927
2024 Q3	$5K	Hold	48	–	–	﹤0.01%	902
2024 Q2	$4K	Hold	48	–	–	﹤0.01%	925
2024 Q1	$4K	Hold	48	–	–	﹤0.01%	903
2023 Q4	$5K	Hold	48	–	–	﹤0.01%	811
2023 Q3	$4K	Hold	48	–	–	﹤0.01%	854
2023 Q2	$4K	Buy	+48	New	+$3.94K	﹤0.01%	862
2022 Q4	–	Sell	-12	Closed	-$1K	–	1194
2022 Q3	$1K	Buy	+12	New	+$1.43K	﹤0.01%	949
2022 Q2	–	Sell	-3	Closed	-$1K	–	983
2022 Q1	$1K	Buy	+3	New	+$448	﹤0.01%	668

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Capital Advisors Ltd's AMED Position: Q3 2025 in Review

Capital Advisors Ltd sold out of Amedisys (AMED) in Q3 2025, closing a stake of 56 shares — an estimated $6K sold.

Capital Advisors Ltd first reported a position in AMED in Q1 2022 and held it in 11 quarters. The position peaked at $6K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Capital Advisors Ltd reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Capital Advisors Ltd sold 56 Amedisys shares in Q3 2025, an estimated $6K.
Capital Advisors Ltd first reported a position in Amedisys in Q1 2022 and held it in 11 quarters.
Capital Advisors Ltd's Amedisys position peaked at $6K in Q2 2025.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Capital Advisors Ltd's 13F filing for Q3 2025, filed 16 Oct 2025.